Molecules / Leuprolide / China

Leuprolide API manufacturers in China

CAS 53714-56-0 ATC L02AE02 Updated 9 July 2026
8
China-based manufacturers with an active filing of 16 worldwide
Showing 4 of 8 China-based manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked China-based API manufacturers

01

Zhejiang Peptites Biotech

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for leuprolide, filing since 2020. Its 2023 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Shanxi Tongda Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for leuprolide, filing since 2024.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile

4 more manufacturers in China hold filings for leuprolide

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Zhejiang Peptites BiotechAlp Pharm BeijingReali Tide Biological Technology (Weihai)Shanxi Tongda Pharmaceutical
Open the full list with a free account

How this list is built

This page filters the worldwide Leuprolide manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.

Map leuprolide for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

All Leuprolide manufacturers

Worldwide 16 India 7